Lexiva
Links shared publicly online about this topic
Symposier - Cardiovascular Problems with Lexiva (February 2010)
symposier.com — “Uploaded and Shared in Youtube by: LawsuitGuru GlaxoSmithKline is notifying healthcare professionals that Lexiva (fosamprenavir calcium), a protease inhibitor, has been associated with an increased risk of myocardial infarction and dyslipidemia in HIV infected adults. The company's letter recommends that patients have their cholesterol and triglycerides tested prior to starting therapy with Lexiva and at periodic intervals during treatment with the drug. The letter also recommends treating ” View full resource at symposier.com
Most Recently Shared on February 4, 2010 at 9:31 pm By:
Symposier Cardiology Cardiology and Health Business
Cardiovascular Problems with Lexiva (fosamprenavir calcium, protease inhibitor) (February 2010) -- >http://ow.ly/13Zgr
FDA Alert: Lexiva (fosamprenavir calcium) - Dear Healthcare Professional Letter
drugs.com — “FDA Alert: Lexiva (fosamprenavir calcium) - Dear Healthcare Professional Letter” View full resource at drugs.com
Most Recently Shared on December 4, 2009 at 7:44 pm By:
FDA Alert - GlaxoSmithKline and FDA Inform Healthcare Professionals of New Warnings for Lexiva (fosamprenavir) - http://bit.ly/8j4QC2
FDA warns of potential cardiovascular risk with Lexiva in HIV-infected patients - MPR
empr.com — “The FDA and GlaxoSmithKline have notified healthcare professionals of a potential association between Lexiva (fosamprenavir calcium) and myocardial infarction and dyslipidemia in HIV-infected adults.” View full resource at empr.com
Most Recently Shared on December 3, 2009 at 10:09 pm By:
MPR News: FDA warns of potential cardiovascular risk with Lexiva in HIV-infected patients: The FDA and GlaxoSmithKl... http://bit.ly/6eyGj4
Forum on Choosing Your Meds: 2ND TIME! IS MY QUESTION NOT IMPORTANT.
thebody.com — “Ask the experts your questions on HIV and AIDS treatment at The Body, the AIDS Authority. Got questions on starting treatment? Want to ask a question about stopping treatment? This is the place to get your questions answered!” View full resource at thebody.com
Most Recently Shared on March 24, 2010 at 2:01 pm By:
Ask the HIV/AIDS Experts: "Lexiva or Prezista: Which PI Should I Choose?" http://bit.ly/9atfVS #hiv #aids #lexiva #prezista
FDA: Link between fosamprenavir and MI, dyslipidemia
theheart.org — “Fosamprenavir calcium is associated with an increased risk of MI and dyslipidemia in HIV-infected adults, according to the FDA.” View full resource at theheart.org
Most Recently Shared on December 8, 2009 at 6:11 pm By:
FDA warning: Increased MI, dyslipidemia with fosamprenavir http://bit.ly/5UVUcD #heartwire
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Symposier Cardiology
Symposier.com, the technological platform that will allow you (and your colleagues) to share medical information, and much more with medicine professionals.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
